This shift in post-translational modification of EB1 may participate to Vinca-alkaloid antitumor activity, if one considers that detyrosinated EB1 promotes tumor progression as described with detyrosinated tubulin [35]. This evidence concerns the gene MAPRE1 and neoplasm.